SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001599298-19-000011
Filing Date
2019-06-12
Accepted
2019-06-12 07:32:54
Documents
60
Period of Report
2019-04-30

Document Format Files

Seq Description Document Type Size
1 6-K a6-kq1april2019xfrontpage.htm 6-K 31343
2 EXHIBIT 99.1 rns-q1april2019.htm EX-99.1 605404
3 EXHIBIT 99.2 ias34-q1april2019.htm EX-99.2 656309
10 summitmasterrgbjpeg.jpg GRAPHIC 65667
  Complete submission text file 0001599298-19-000011.txt   4974085

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT smmt-20190430.xml EX-101.INS 985984
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT smmt-20190430.xsd EX-101.SCH 42302
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT smmt-20190430_cal.xml EX-101.CAL 65471
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT smmt-20190430_def.xml EX-101.DEF 131621
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT smmt-20190430_lab.xml EX-101.LAB 440402
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT smmt-20190430_pre.xml EX-101.PRE 249625
Mailing Address 136A EASTERN AVENUE MILTON PARK ABINGDON X0 OX14 4SB
Business Address 136A EASTERN AVENUE MILTON PARK ABINGDON X0 OX14 4SB 44-123-544-3939
Summit Therapeutics plc (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0131
Type: 6-K | Act: 34 | File No.: 001-36866 | Film No.: 19892431
SIC: 2834 Pharmaceutical Preparations